510(k) Report

510(k) · Cleared

Recalled · Class II · 2021

Revolution Ascend

K203169510(k) SpecialCleared Nov 20, 202028-day reviewClass II21 CFR 892.1750Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ge Healthcare Japan Corporation · JAK System, X-Ray, Tomography, Computed

Cleared on Nov 20, 2020 as substantially equivalent to K192686 (Ge Hangwei Medical Systems Co., Ltd., 2019) after a 28-day review. Its family tree reaches back 8 generations to 2001. 3 later devices descend from it. It has been recalled once.

Decided
Nov 20, 2020
Review
28 days
Class
Class II
Product code
JAK
Recalls
1
Predicates
1

Its longest line of descent runs back 8 generations to K013561 (2001). 3 later devices descend from it, 1 citing it directly.

  1. Root · 8 generations backK013561 Lightspeed 4.0 CT Scanner SystemGE Medical Systems · 2001 · Recalled
  2. 7 generations backK030420 Lightspeed 5.0 Computed Tomography SystemGE Medical Systems · 2003 · Recalled
  3. 6 generations backK040372 Lightspeed 7.0 CT Scanner SystemGe Medical Systems, LLC · 2004 · Recalled
  4. 5 generations backK061817 Lightspeed 7.1 CT Scanner SystemGe Medical Systems, LLC · 2006 · Recalled
  5. 4 generations backK082761 GE Lightspeed 7.2 CT Scanner SystemGe Medical Systems, LLC · 2008 · Recalled
  6. 3 generations backK110227 Optima CT660Ge Medical Systems, LLC · 2011 · Recalled
  7. 2 generations backK131576 Optima CT660Ge Medical Systems, LLC · 2013 · Recalled
  8. 1 generation backK192686 Revolution Maxima, Revolution AceGe Hangwei Medical Systems Co., Ltd. · 2019 · Recalled
  9. This deviceK203169 Revolution AscendGe Healthcare Japan Corporation · 2020
  10. Descendant · cites it directly · 2 of its ownK213938 Revolution AscendGe Healthcare Japan Corporation · 2022 · Recalled
  11. Descendant · 2 generations on · 0 of its ownK233698 True Enhance DLGe Healthcare Japan Corporation · 2024
  12. Descendant · 2 generations on · 0 of its ownK233749 Revolution Ascend SlidingGe Hangwei Medical Systems Co., Ltd. · 2024

Most influential descendants

Showing 3 of 3 · See all
  • K213938Revolution AscendGe Healthcare Japan Corporation · 2022 · cites it directly2descendants
  • K233698True Enhance DLGe Healthcare Japan Corporation · 2024 · 2 generations on0descendants
  • K233749Revolution Ascend SlidingGe Hangwei Medical Systems Co., Ltd. · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K013561Lightspeed 4.0 CT Scanner SystemGE Medical Systems20015
−7K030420Lightspeed 5.0 Computed Tomography SystemGE Medical Systems20034
−6K040372Lightspeed 7.0 CT Scanner SystemGe Medical Systems, LLC20045
−5K061817Lightspeed 7.1 CT Scanner SystemGe Medical Systems, LLC20061
−4K082761GE Lightspeed 7.2 CT Scanner SystemGe Medical Systems, LLC20083
−3K110227Optima CT660Ge Medical Systems, LLC20115
−2K131576Optima CT660Ge Medical Systems, LLC20138
−1K192686Revolution Maxima, Revolution AceGe Hangwei Medical Systems Co., Ltd.20195
0 (this device)K203169Revolution AscendGe Healthcare Japan Corporation2020—
+1K213938Revolution AscendGe Healthcare Japan Corporation20222
+2K233698True Enhance DLGe Healthcare Japan Corporation2024—
+2K233749Revolution Ascend SlidingGe Hangwei Medical Systems Co., Ltd.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
202420
FIG. 1 — Lineage of K203169, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAK device

  1. #1 K230223 iCAC Devicescore 23.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K192686Revolution Maxima, Revolution Ace
Summary page 5
…Hino-shi, Tokyo, 191-8503, Japan Predicate Device Information: Device Name Revolution Maxima 510 (K) number K192686 cleared on October, 2019 Regualation Number/ Computed Tomography X-ray System, 21 CFR 892.1750 / Classification…
Ge Hangwei Medical Systems Co., Ltd.20195
†K153429SmartView 3D OptionGe Hangwei Medical System Co., Ltd.2016—
†K171013Revolution ACTGe Hangwei Medical Systems Co., Ltd.2017—
†K133705Revolution CTGe Medical Systems, LLC201414

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K213938Revolution AscendGe Healthcare Japan Corporation20222

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 30, 2021Class IIZ-2023-2021Process designWhen adding one or more intended scan groups names must contain only letters, numbers (0-9), or a space or the user interface will not update to confirm the intended group(s) has been added to the acquisition.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 4 companies; a new generation was cleared every 2.2 years on median.
  • 8 of the 8 ancestors have a recall of any class.
  • Of its descendants, K213938 (Ge Healthcare Japan Corporation, 2022) has gone furthest, with 2 descendants of its own.

How does its category compare?

All JAK devices

JAK System, X-Ray, Tomography, Computed: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · JAK

27in 2025

2007: 142008: 262009: 152010: 72011: 162012: 282013: 172014: 302015: 302016: 252017: 292018: 242019: 282020: 302021: 202022: 302023: 272024: 262025: 272026 (partial year): 21
2007high 30 (2014) · low 7 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAK

141in 2025

2007: 27 days median2008: 42 days median2009: 31 days median2010: 92 days median2011: 155 days median2012: 121 days median2013: 132 days median2014: 200 days median2015: 140 days median2016: 129 days median2017: 96 days median2018: 114 days median2019: 94 days median2020: 112 days median2021: 145 days median2022: 131 days median2023: 139 days median2024: 141 days median2025: 141 days median2026 (partial year): 167 days median
2007high 200 (2014) · low 27 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAK

17in 2025

2007: 112008: 162009: 292010: 512011: 342012: 232013: 112014: 102015: 282016: 442017: 332018: 102019: 52020: 82021: 152022: 92023: 92024: 202025: 172026 (partial year): 23
2007high 51 (2010) · low 5 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAK

219in 2025

2007: 762008: 1202009: 1052010: 1192011: 2052012: 1922013: 4142014: 3082015: 4542016: 3652017: 3382018: 5432019: 2332020: 1772021: 2612022: 1992023: 3102024: 2122025: 219
2007high 543 (2018) · low 76 (2007)2025

MAUDE reports naming product code JAK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200714271176
2008264216120
2009153129105
201079251119
20111615534205
20122812123192
20131713211414
20143020010308
20153014028454
20162512944365
2017299633338
20182411410543
201928945233
2020301128177
20212014515261
2022301319199
2023271399310
20242614120212
20252714117219
20262116723—

What is it indicated for?

The system is intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data taken at different angles and planes, including Axial, Cine, Helical (Volumetric), Cardiac, and Gated acquisitions. These images may be obtained either with or without contrast. This device may include signal analysis and display equipment, patient and equipment supports, components and accessories. This device may include data and…

Read the full statement (136 words)

The system is intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data taken at different angles and planes, including Axial, Cine, Helical (Volumetric), Cardiac, and Gated acquisitions. These images may be obtained either with or without contrast. This device may include signal analysis and display equipment, patient and equipment supports, components and accessories.

This device may include data and image processing to produce images in a variety of trans-axial and reformatted planes. Further the images can be post processed to produce additional imaging planes or analysis results.

The system is indicated for head, whole body, cardiac and vascular X-ray Computed Tomography applications in patients of all ages.

The device output is a valuable medical tool for the diagnosis of disease, trauma, or abnormality and for planning, guiding, and monitoring therapy.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K203169: Revolution Ascend.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203169

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026